174 related articles for article (PubMed ID: 19680002)
1. Beta-lactamase producing Acinetobacter species in hospitalized patients.
Kansal R; Pandey A; Asthana AK
Indian J Pathol Microbiol; 2009; 52(3):456-7. PubMed ID: 19680002
[No Abstract] [Full Text] [Related]
2. Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.
Fernández-Cuenca F; Rodríguez-Martínez JM; Gómez-Sánchez MA; de Alba PD; Infante-Martínez V; Pascual A
Int J Antimicrob Agents; 2012 Jan; 39(1):93-4. PubMed ID: 21982835
[No Abstract] [Full Text] [Related]
3. Nosocomial spread of OXA-23 and OXA-58 beta-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital.
Stoeva T; Higgins PG; Savov E; Markovska R; Mitov I; Seifert H
J Antimicrob Chemother; 2009 Mar; 63(3):618-20. PubMed ID: 19147517
[No Abstract] [Full Text] [Related]
4. First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.
Boo TW; Walsh F; Crowley B
J Antimicrob Chemother; 2006 Nov; 58(5):1101-2. PubMed ID: 16916867
[No Abstract] [Full Text] [Related]
5. Detection and characterisation of AmpC β-lactamase-producing isolates of Acinetobacter spp. in North India.
Upadhyay S; Sen MR; Prakash P; Anupurba S; Nath G; Bhattacharjee A
Int J Antimicrob Agents; 2010 Nov; 36(5):472-3. PubMed ID: 20843663
[No Abstract] [Full Text] [Related]
6. Activities of cefepime and five other antibiotics against nosocomial PER-1-type and/or OXA-10-type beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp.
Vahaboglu H; Saribaş S; Akbal H; Ozturk R; Yucel A
J Antimicrob Chemother; 1998 Aug; 42(2):269-70. PubMed ID: 9738851
[No Abstract] [Full Text] [Related]
7. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France.
Poirel L; Karim A; Mercat A; Le Thomas I; Vahaboglu H; Richard C; Nordmann P
J Antimicrob Chemother; 1999 Jan; 43(1):157-8. PubMed ID: 10381117
[No Abstract] [Full Text] [Related]
9. OXA-23-producing Acinetobacter species from horses: a public health hazard?
Smet A; Boyen F; Pasmans F; Butaye P; Martens A; Nemec A; Deschaght P; Vaneechoutte M; Haesebrouck F
J Antimicrob Chemother; 2012 Dec; 67(12):3009-10. PubMed ID: 22872446
[No Abstract] [Full Text] [Related]
10. First identification of VIM-4 metallo-beta-lactamase in Acinetobacter spp.
Figueiredo S; Poirel L; Papa A; Koulourida V; Nordmann P
Clin Microbiol Infect; 2008 Mar; 14(3):289-90. PubMed ID: 18190570
[No Abstract] [Full Text] [Related]
11. OXA (beta)-lactamases in Acinetobacter: the story so far.
Brown S; Amyes S
J Antimicrob Chemother; 2006 Jan; 57(1):1-3. PubMed ID: 16332731
[TBL] [Abstract][Full Text] [Related]
12. New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor.
Schuelter-Trevisol F; Schmitt GJ; Araújo JM; Souza LB; Nazário JG; Januário RL; Mello RS; Trevisol DJ
Rev Soc Bras Med Trop; 2016 Feb; 49(1):130-4. PubMed ID: 27163578
[TBL] [Abstract][Full Text] [Related]
13. Clonal dissemination of two clusters of Acinetobacter baumannii producing OXA-23 or OXA-58 in Rome, Italy.
Mendes RE; Spanu T; Deshpande L; Castanheira M; Jones RN; Fadda G
Clin Microbiol Infect; 2009 Jun; 15(6):588-92. PubMed ID: 19438644
[TBL] [Abstract][Full Text] [Related]
14. IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan.
Endo S; Sasano M; Yano H; Inomata S; Ishibashi N; Aoyagi T; Hatta M; Gu Y; Yamada M; Tokuda K; Kitagawa M; Kunishima H; Hirakata Y; Kaku M
J Antimicrob Chemother; 2012 Oct; 67(10):2533-4. PubMed ID: 22733654
[No Abstract] [Full Text] [Related]
15. First report of the emergence of New Delhi metallo-β-lactamase-1 producing Acinetobacter junii in Nanjing, China.
Zhou WQ; Zhang ZF; Shen H; Ning MZ; Xu XJ; Cao XL; Zhang K
Indian J Med Microbiol; 2013; 31(2):206-7. PubMed ID: 23867689
[No Abstract] [Full Text] [Related]
16. PER-1-type extended-spectrum beta-lactamase-producing Acinetobacter baumannii clinical isolates from India.
Litake GM; Ghole VS; Niphadkar KB; Joshi SG
Int J Antimicrob Agents; 2009 Oct; 34(4):388-9. PubMed ID: 19589658
[No Abstract] [Full Text] [Related]
17. Emergence of metallo-beta-lactamases in Acinetobacter spp clinical isolates from Argentina.
Fiorilli G; Faccone D; Lopardo H; Callejo R; Rapoport M; Prieto M; Galas M; Pasteran F
Rev Esp Quimioter; 2010 Jun; 23(2):100-2. PubMed ID: 20559609
[No Abstract] [Full Text] [Related]
18. [Microbiological and therapeutic considerations of Acinetobacter spp. infection].
López-Brea M; Alarcón T; López S
Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295
[No Abstract] [Full Text] [Related]
19. Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy.
Dalben MF; Oliveira MS; Garcia CP; Lobo RD; Costa SF; Toscano CM; Levin AS
J Hosp Infect; 2010 Apr; 74(4):395-6. PubMed ID: 19717211
[No Abstract] [Full Text] [Related]
20. Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
Mugnier PD; Bindayna KM; Poirel L; Nordmann P
J Antimicrob Chemother; 2009 May; 63(5):1071-3. PubMed ID: 19252183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
